Assessing BioNTech: Insights From 11 Financial Analysts
Assessing BioNTech: Insights From 11 Financial Analysts
Ratings for BioNTech (NASDAQ:BNTX) were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 6 | 2 | 2 | 1 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 1 | 1 | 1 | 0 |
2M Ago | 3 | 1 | 1 | 0 | 0 |
3M Ago | 1 | 0 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $130.82, a high estimate of $171.00, and a low estimate of $90.00. Witnessing a positive shift, the current average has risen by 4.66% from the previous average price target of $125.00.
Understanding Analyst Ratings: A Comprehensive Breakdown
The standing of BioNTech among financial experts is...
在過去三個月中,11位分析師提供了BioNTech(納斯達克股票代碼:BNTX)的評級,顯示了看漲和看跌的觀點。
下表總結了他們最近的評估,說明了過去30天不斷變化的情緒,並將其與前幾個月進行了比較。
看漲 | 有點看漲 | 漠不關心 | 有點看跌 | 看跌 | |
---|---|---|---|---|---|
評分總數 | 6 | 2 | 2 | 1 | 0 |
最後 30D | 1 | 0 | 0 | 0 | 0 |
1 個月前 | 1 | 1 | 1 | 1 | 0 |
2 個月前 | 3 | 1 | 1 | 0 | 0 |
3M 之前 | 1 | 0 | 0 | 0 | 0 |
分...
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧